Zacks Research Issues Optimistic Estimate for AGIO Earnings
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Stock analysts at Zacks Research lifted their Q2 2025 EPS estimates for shares of Agios Pharmaceuticals in a research note issued to investors on Thursday, May 22nd. Zacks Research analyst A. Chakraborty now forecasts that the biopharmaceutical company will post earnings of ($1.77) per share for the […]
More Stories
Georgia’s Fulton County Sues for Return of 2020 Election Documents Seized by FBI
By Matthew Vadum Fulton County, Georgia, is suing the federal government for the return of 2020 election documents that the...
DNC Targets 2020 Voters Who Skipped 2024 With New Outreach Push
By Chase Smith The Democratic National Committee (DNC) announced on Wednesday a new voter contact and volunteer training program that...
3 US Warships Dispatched to Haiti as Part of Campaign Against Drug Traffickers
By Chris Summers Three U.S. warships have been sent to Haiti as part of Operation Southern Spear, a military operation...
Sheriff in Nancy Guthrie Case Urges Public Not to Share Unverified Accusations
By Jack Phillips An Arizona sheriff’s department on Feb. 4 said that people should not share “unverified accusations” in response...
US Private Payrolls Growth Slows to Start 2026: ADP
By Andrew Moran U.S. private payroll growth cooled at the start of 2026, rising at a slower‑than‑expected pace, according to...
The Empress Season 3, Final Season: Release Date, Cast, and Updates
Netflix’s German television series, The Empress, season 3, is returning soon. The shooting is ongoing. For season 3, it is...